Jason Itkin Featured in New York Times Story on Roundup Litigation

In a recent New York Times article, the spotlight was on Jason Itkin and the firm’s significant impact on the ongoing Roundup litigation against Bayer, the owner of Monsanto. The article underscores the influence of the firm’s successes in changing the tide of the Roundup litigation.  

Jason Itkin and his-co-counsel not only won a $175 million jury verdict against Monsanto for a cancer victim, but they shared evidence with other lawyers for cancer victims to help them win nearly $2 billion in damages.  

The Domino Effect in Roundup Litigation 

Arnold & Itkin is scheduled to try more than a dozen Roundup cases in 2024. The firm’s skill and work ethic could bring closure to this dark chapter in Monsanto’s history. 

Bayer’s acquisition of Monsanto in 2018 for $63 billion is now considered one of the worst mergers in history. Since the merger, Bayer’s stock value has plummeted by 60%, with the company’s market cap falling to $33 billion. 

The New York Times article not only highlights the legal complexities surrounding Bayer and Roundup but also emphasizes the influential role Arnold & Itkin has played in shaping this high-stakes legal struggle.  

This article is yet more evidence that a victory for our clients is a win for the public at large.